ANTX vs MSFT: Which Stock is Better?
Side-by-side comparison of An2 Therapeutics Inc and Microsoft Corp in 2026
ANTX
An2 Therapeutics Inc
$2.85
MSFT
Microsoft Corp
$408.40
Key Metrics Comparison
| Metric | ANTX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $46.86M | N/A | ANTX |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 0.0% | 68.8% | MSFT |
Analyze ANTX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANTX or MSFT a better investment?
Comparing ANTX and MSFT: An2 Therapeutics Inc has a market cap of $46.86M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANTX and MSFT?
ANTX (An2 Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANTX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANTX or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for ANTX.
Which company is more profitable: ANTX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for ANTX.
Which is the larger company: ANTX or MSFT?
An2 Therapeutics Inc (ANTX) is larger with a market cap of $46.86M compared to N/A for MSFT.
Should I buy ANTX or MSFT in 2026?
Both ANTX and MSFT have investment merit. ANTX trades at $2.85 while MSFT trades at $408.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANTX and MSFT stock?
Key differences: Market Cap ($46.86M vs N/A), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).